Clinical trial
Vancomycin Study in Multiple Sclerosis (MS)
NCT05539729
Study timeline
Study start (actual)2023-01-31Date precision: day
Registry last updated2026-09-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosisunresolved
Interventions
VancomycinDRUG · verified · RxNorm: vancomycin
PlaceboDRUG
Sponsors & collaborators
Icahn School of Medicine at Mount Sinailead sponsor
Doris Duke Charitable Foundationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05539729 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.